KalshiVerifica disponibilitàKYC richiesto2% di commissioneDati di risoluzione verificatiDiscretamente calibratoProbabilità implicita attuale
Before 2028 92%In testa tra 5 esiti
Qualità del mercato
46 / 100
Bassa qualitàVolume 24h
—
Liquidità
7,2K €
Liquidità mediaSpread
5.0 pt
Spread moderatoDati di mercato
Aggiornato 10 minuti fa
16 mag 26, 02:30 UTC1 gen 27, 04:59 UTC
Trend
Mercati Correlati
Domande correlate per il contesto, non un confronto tra contratti equivalenti.
When will Compass Pathways submit a NDA for COMP360 psilocybin?
Kalshi[ACX 2026] Will the FDA approve a psilocybin treatment during 2026?
Manifold MarketsWill the FDA approve a psilocybin treatment during 2026?
FutuurWill the FDA approve any psychedelic substance for medical use this year?
KalshiWill the FDA approve a psychedelic-assisted therapy for a mental disorder by 2027?
Manifold MarketsWill the FDA approve intismeran autogene (V940/mRNA-4157)?
KalshiRegole
If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing the named outcome, then the market resolves to Yes.
- If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jul 1, 2027, then the market resolves to Yes.
- If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Oct 1, 2027, then the market resolves to Yes.
- If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing before Jan 1, 2028, then the market resolves to Yes.
Mercati aperti
Health & Medicine
POLYMARKETHantavirus pandemic in 2026?
- No+0.4pt97%
- Yes-0.4pt3%
- Volume totale
- 15,7 Mln €
- Volume 24h
- 52,2K €
KALSHIMeasles cases in 2026?
- Above 4000+2.0pt99%
- Above 300099%
- Above 600061%
+2 altri esiti
- Volume totale
- 870,4K €
- Volume 24h
- 2,1K €
POLYMARKETNew pandemic in 2026?
- No-1.0pt93.1%
- Yes+1.0pt6.9%
- Volume totale
- 922,5K €
- Volume 24h
- 1,8K €
KALSHICyclosporiasis cases reported in the US in 2026?
- Above 18k99%
- Above 6k99%
- Above 10k99%
+12 altri esiti
- Volume totale
- 32,4K €
- Volume 24h
- 1,3K €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No97%
- Yes+0.4pt3%
- Volume totale
- 1,6 Mln €
- Volume 24h
- 933,9 €
KALSHIHealthcare AI adoption in September
- Above 43%87%
- Above 43.75%59%
- Above 45%14%
+4 altri esiti
- Volume totale
- 810,1 €
- Volume 24h
- 767 €
- FDA decision: Ivonescimab by Summit Therapeutics (in 2026)
- Measles cases in U.S. in 2026?
- Measles cases in U.S. by September 30?
- What will the average number of measles cases be during Trump's term?
- When will Beam Therapeutics submit a BLA for Risto-cel?
- Will the FDA approve any psychedelic substance for medical use this year?
- Pandemic in 2026?
- How many human screwworm cases will be reported in the United States in 2026?
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- Which countries will have an Ebola case in 2026?
- Ebola: new country confirmed before October 1?
Domande frequenti
- Quali sono le probabilità attuali per When will the FDA approve Compass Pathways' COMP360 Psilocybin??
- Kalshi quota Before 2028 al 92% al 11 settembre 2026.
- Quando si risolve When will the FDA approve Compass Pathways' COMP360 Psilocybin??
- When will the FDA approve Compass Pathways' COMP360 Psilocybin? dovrebbe risolversi il 1 gennaio 2027.
- Come viene liquidato When will the FDA approve Compass Pathways' COMP360 Psilocybin??
- Kalshi liquida questo mercato come segue: If the FDA approves COMP360 Psilocybin for Treatment-Resistant Depression for marketing the named outcome, then the market resolves to Yes.